Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIS-guided remimazolam tosylate administration in elderly patients undergoing colonoscopy
ChiCTR2300070114Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Blood pressure. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2300070114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070114.